Healthcare at Luna Innovations

Luna has signed a marketing agreement with Terumo Cardiovascular Systems, the world's leading supplier of products for cardiopulmonary bypass.
Luna Innovations is focused on applying emerging technologies to develop products to overcome challenges faced by the healthcare community. Products and R&D include:
- Fiber optic sensors to provide motion and control over surgical tools, as well as real-time shape or position tracking
- Luna Innovations Signs Multi-Year Development and Supply Agreement with Intuitive Surgical
- Sensing System Maps Fibre Position and Shape in Medical Applications, Nature Photonics
- NASA-Inspired Shape-Sensing Fibers Enable Minimally Invasive Surgery, NASA Tech Briefs
- Enhancing Magnetic Resonance Imaging (MRI) contrast agents to reduce toxicity while increasing sensitivity of diagnostic imaging for improved disease detection
- Luna Innovations Receives Funding for Brain Cancer Diagnostic Agent Using Nanotechnology
- Luna nanoWorks' Next-Generation MRI Contrast Agent Breakthrough Published in Journal of Medicinal Chemistry
- Luna Innovations Successfully Demonstrates MRI Contrast Agent
- Luna Works with the National Institutes of Health Exploring New Diagnostics for Heart Attack Prevention
- Luna Innovations Plans Preclinical Studies and Collaboration with National Cancer Institute
- The Contrast Continuum Medical Imaging Magazine
- Nanosphere compounds tailored to treat specific diseases and conditions, such as allergy and hair loss
- Luna Awarded NIH Grant to Apply Nanotechnology to Allergy Treatment
- Luna Discovers Nanomedicine Prototype Affects Hair Growth
- First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
- Medical devices utilizing advanced quantitative ultrasonic technology and minimally-invasive biosensors
- Luna's Emboli Detection System Reviewed in Leading Medical Publication
- Luna Innovations Signs Marketing Agreement with Terumo Cardiovascular Systems
- Luna Innovations Blood Circuit Monitor Receives FDA Clearance
- Therapeutic to treat disease using cell's signaling pathway
- Biomaterials including antimicrobial bone graft substitutes, hemostatic agents and tissue adhesives
Read more:
Read more:
Read more:
Read more:
Read more: